Bone events and evolution of biologic markers in Gaucher disease before and during treatment. - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Arthritis Research and Therapy Année : 2010

Bone events and evolution of biologic markers in Gaucher disease before and during treatment.

Résumé

INTRODUCTION : Known biomarkers of Gaucher-disease activity are platelets, chitotriosidase, angiotensin-converting enzyme (ACE), tartrate-resistant acid phosphatase (TRAP) and ferritin. The aim of this study was to retrospectively evaluate the frequency of bone events (BE) and biomarker changes during two periods: diagnosis to first enzyme-replacement therapy (ERT) and the latter to the closing date. METHODS : BE of 62 treated patients, among the 73-patient cohort followed at Beaujon Hospital, Clichy, France, were described with Kaplan-Meier curves, and linear-mixed models were used to analyze their biomarker changes and the influence of several covariates (splenectomy, diagnosis year, genotype, age at diagnosis and sex). RESULTS : BE occurred before (54 events in 21 patients), but also during, ERT (12 events in 10 patients), with respective frequencies (95% confidence interval) at 10 years of 22.4% (13.3 to 36.3) and 20.0% (10.2 to 36.9). Biomarker slope changes before and during ERT differed significantly for platelets (+190/mm3/year and 7,035/mm3/year, respectively; P < 0.0001) and ferritin (+4% and -14%; P < 0.0001). High ferritin levels and low platelet counts at ERT onset were significantly associated with BE during ERT (P = 0.019 and 0.039, respectively). Covariates significantly influenced biomarker changes (baseline and/or slope): splenectomy affected platelets (baseline and changes), TRAP changes and chitotriosidase changes; diagnosis date influenced ACE and TRAP baseline values; and genotype influenced chitotriosidase baseline and changes. CONCLUSIONS : Platelet counts and ferritin levels and their slope changes at ERT onset seem to predict BE during treatment. Biomarker baseline values and changes are dependent on several covariables.
Fichier principal
Vignette du fichier
ar3111.pdf (626.9 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte
Loading...

Dates et versions

inserm-00544232 , version 1 (07-12-2010)

Identifiants

Citer

Jérôme Stirnemann, Nadia Belmatoug, Corine Vincent, Olivier Fain, Bruno Fantin, et al.. Bone events and evolution of biologic markers in Gaucher disease before and during treatment.. Arthritis Research and Therapy, 2010, 12 (4), pp.R156. ⟨10.1186/ar3111⟩. ⟨inserm-00544232⟩

Collections

INSERM UNIV-PARIS7
158 Consultations
183 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More